{"schema_version":"secwatch.filing_event.v1","accession":"0001035267-22-000165","form_type":"8-K","ticker":"ISRG","cik":"0001035267","company_name":"INTUITIVE SURGICAL INC","filed_at":"2022-10-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.335679+00:00","generated_at":"2026-06-23T02:51:24.569856+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Intuitive Q3 revenue $1.56B up 11% YoY; GAAP EPS $0.90 vs $1.04","bullets":["Worldwide da Vinci procedures grew ~20% YoY; installed base 7,364 systems (+13%).","System placements of 305, down 9% from 336 in Q3 2021.","Non-GAAP EPS $1.19 flat YoY; GAAP net income $324M vs $381M.","Repurchased $1B of common stock in Q3 2022.","Japan cleared da Vinci SP for several surgical indications in September 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001035267-22-000165","json":"https://secwatch.observer/filing/0001035267-22-000165.json","markdown":"https://secwatch.observer/filing/0001035267-22-000165.md","text":"https://secwatch.observer/filing/0001035267-22-000165.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1035267/000103526722000165/0001035267-22-000165-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1035267/000103526722000165/isrg-20221018.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T02:51:24.569856+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}